The risk of<unk>  varies based on the type of treatment received as well as several outside factors. Some types of<unk>  are more prone to causing<unk>  and<unk>  than others. Some<unk> utic agents may not cause<unk>  and<unk>  on their own, but may when used in combination with other agents. Regimens that are linked to a high incidence (90% or higher) of<unk>  and<unk>  are referred to as "highly emetogenic<unk> ", and those causing a moderate incidence (30–90%) of<unk>  and<unk>  are referred to as "moderately emetogenic<unk> ". Some highly emetogenic agents and<unk>  regimens include: *ABVD *AC *BEP *Cisplatin *Carmustine (>250 mg/m2) *CBV *Cyclophosphamide (>1500 mg/m2) *Dacarbazine *Mechlorethamine *MOPP/COPP/BEACOPP *Streptozocin *VIP Some moderately emetogenic agents and regimens include: *Carboplatin *CHOP/CHOP-R *Cyclophosphamide (≤1500 mg/m2) *Docetaxel *Doxorubicin/Adriamycin *Etoposide *Ifosfamide *Methotrexate *Paclitaxel Besides the type of treatment, personal factors may put a patient at greater risk for<unk> . Other risk factors include: *Anticipation of<unk>  *Anxiety or depression *Female sex *History of light alcohol use *History of motion sickness *History of<unk>  and<unk>  during pregnancy *History of previous<unk>  *Patient age (under 55 years old)
Chemotherapy-induced nausea and vomiting
Cyclic vomiting syndrome
Dumping syndrome
Alimentary toxic aleukia
Refeeding syndrome
Infection-induced anorexia
Acute HME syndrome
Paraneoplastic syndrome